INCB50465-205

Research code: INCB50465-205
Research name: Open-label, multicentre phase II research conducted in two cohorts evaluating INCB050465, a PI3Kδ inhibitor, in the treatment of relapsed mantle cell lymphoma or refractory mantle cell lymphoma previously treated or untreated with a BTK inhibitor (CITADEL-205).
Indication: lymphoma
Principal researcher: Ewa Chmielowska, MD, PhD